NCT06456580 2026-03-10A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)Vor BiopharmaPhase 3 Recruiting180 enrolled
NCT07249632 2026-01-15A Study of Telitacicept in Patients With Ocular Myasthenia Gravis (OMG)RemeGen Co., Ltd.Phase 3 Recruiting120 enrolled
NCT05737160 2025-05-23Study of Telitacicept in Generalized Myasthenia GravisRemeGen Co., Ltd.Phase 3 Completed114 enrolled